Comments
Drug maker Divi’s Laboratories on Wednesday said its unit at Choutuppal in Telangana has undergone successful inspection by the US Food and Drug Administration (USFDA) from May 14-16, without any observations. The unit is engaged in active pharmaceutical ingredients and intermediates for generics. Apart from this, Divi’s Laboratories has a facility in Visakhapatnam. Shares of Divi’s Labs may react positively at the bourses following the green signal from the USFDA.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.